M2 Sequence Overview
Hematology/Oncology
Sequence Directors

Paula Bockenstedt, M.D.
Professor, Internal Medicine
Email: pbockens@umich.edu

Lloyd M. Stoolman, M.D.
Professor, Pathology
Email: stoolman@umich.edu

Sequence Description

The following are a summary of the objectives for the Hematology/Oncology sequence.

By the end of the Hematology/Oncology sequence, students will be able to:

  • Describe the general origin, function and component parts of the hematopoietic system.
  • Define the diagnostic evaluation and treatment of patients with anemia.
  • Identify the major causes of bleeding disorders, and describe the diagnostic and therapeutic approach for each of them.
  • Identify the causes of thrombosis, describe the disorders associated with thromboembolic disease and identify appropriate therapies for these disorders.
  • Describe the clinical presentation, laboratory findings and therapeutic approach in patients with lymphoma and leukemia.
  • Demonstrate the ability to identify normal cells on a peripheral blood smear, and to accurately describe red cell morphology
  • Describe the indications for bone marrow aspiration, bone marrow biopsy and lymph node biopsy
  • List the indications for and the hazards of whole blood, packed red cell, platelet and plasma component transfusions.
s